Newsroom for Journalists & Media Relations
BEAMER: Quick Insights About The Project
This infographic briefly describes the implications of non-adherence and how the BEAMER project will help address the major health issue
BEAMER in The Spotlight
PORTUGAL: Universidade do Porto lidera projeto internacional de 12 milhões que visa investigar adesão terapêutica
SPAIN: Inteligencia artificial para mejorar la adherencia y eficacia de los tratamientos médicos
Trending News
Coming Soon
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
